New-found drug could help sufferers

The charity founded by MS sufferer Linda Elsegood has worked tirelessly to raise awareness for Low-dose Naltrexone (LDN), after she discovered its incredible benefits.

LDN uses 1 per cent of the Naltrexone dose approved by the Food and Drug Administration for treating alcoholism and drug addiction.

It is non-toxic and prescribed ‘off label’ on the NHS to treat diseases such as MS, cancer, Alzheimer’s, Crohns and Parkinson’s.

“My MS had become so severe I was in a wheelchair, had lost half of my hearing and part of my sight,” says Linda Elsegood.

“After discovering LDN my life has been completely transformed. I feel like a new person.

“I still have MS but life is good

“I can set targets and achieve them and look forward to the future.

“The other prescribed treatments had horrendous side effects and cannabis was not an option for me.

“After my success with LDN, I wanted everyone to know about it. I formed the LDN Research Trust in May 2004 and now spend all my time helping others while trying to raise funds for clinical trials

“Naltrexone is a generic drug that is out of patent, so very cheap to produce. The downside of that is that drug companies will not fund trials, as there is no money to be made

“I’d like the Government to fund clinical trials as I believe this could change the lives of thousands of people in the UK who suffer not only from MS but also Crohn’s, cancer and other diseases,” she added.

The LDN research trust says: “LDN is a cheap drug which can be prescribed on the NHS if the prescribing doctor thinks it’s of benefit, however many people have to obtain a private prescription and pay themselves.”